Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
C98-001
Study information
Scientific title
Acronym
Study hypothesis
Not provided at time of registration
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Hospitals
Trial type
Treatment
Patient information sheet
Condition
Seasonal allergic rhinitis
Intervention
Patients randomly assigned once-daily (QD) SCH34117 at doses of 2.5, 5, 7.5, 10, or 20 mg versus placebo for two weeks.
Intervention type
Drug
Phase
Not Specified
Drug names
SCH34117
Primary outcome measures
Not provided at time of registration
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/04/1998
Overall trial end date
01/06/1998
Reason abandoned
Eligibility
Participant inclusion criteria
Subjects 12 years or older with a two-year documented history of seasonal allergic rhinitis and otherwise in good health
Participant type
Patient
Age group
Not Specified
Gender
Not Specified
Target number of participants
1026
Participant exclusion criteria
Not provided at time of registration
Recruitment start date
01/04/1998
Recruitment end date
01/06/1998
Locations
Countries of recruitment
United States of America
Trial participating centre
Medical officer
Kenilworth
NJ 07033-0530
United States of America
Sponsor information
Organisation
Schering-Plough Research Institute (SPRI) (USA)
Sponsor details
2015 Galloping Hill Road
K-15-4
Kenilworth
NJ 07033-0530
United States of America
Sponsor type
Industry
Website
Funders
Funder type
Industry
Funder name
Schering-Plough Research Institute (SPRI) (USA)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
Results in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=12162793
Publication citations
-
Results
Salmun LM, Lorber R, 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]., BMC Fam Pract, 2002, 3, 14.